Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model

Abstract

A cutaneous melanoma mouse model was used to test the efficacy of a new therapeutical approach that uses low doses of cytostatics in conjunction with mild whole body microwave exposure of 2.45 GHz in order to enhance cytostatics antitumoral effect. Materials and Methods. A microwave exposure system for C57BL/6 mouse whole body microwave irradiation was designed; groups of 40 mice (males and females) bearing experimental tumours were subjected to a combined therapy comprising low doses of dacarbazine in combination with mild whole body irradiation. Clinical parameters and serum cytokine testing using xMAP technology were performed. Results. The group that was subjected to combined therapy, microwave and cytostatic, had the best clinical evolution in terms of overall survival, tumour volume, and metastatic potential. At day 14 the untreated group had 100% mortality, while in the combined therapy group 40% of mice were surviving. Quantifying serum IL-1β, IL-6, IL-10, IL-12 (p70), IFN-γ, GM-CSF, TNF-α, MIP-1α, MCP-1, and KC during tumorigenesis and therapy found that the combined experimental therapy decreases all the inflammatory cytokines, except chemokine MCP-1 that was found increased, suggesting an increase of the anti-tumoral immune response triggered by the combined therapy. The overall metastatic process is decreased in the combined therapy group.

Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis

“…Thus, in melanoma patients, IL-6 increases with stage, as does TNF-alpha and IL-8; IL-6 being positively correlated with other serum markers tested in our patients, like S100 and MIA 31,94 . IL-6 can pin-point the overall survival of the patient and the circulating levels of IL-1beta can indicate the metastatic processes evolution.…”

Inflammatory Cytokine Pattern Is Sex-Dependent in Mouse Cutaneous Melanoma Experimental Model

“…Our own experience has shown, whether in human samples or in mouse melanoma models [ 49 ], that circulatory cytokines have different patterns matching the cutaneous melanoma stages and most probably the clinical evolution of the patients [ 15 , 50 , 51 ].…”

Chemically induced skin carcinogenesis: Updates in experimental models (Review)

“…Bridging the early studies of 'inflammation', as carcinogenesis points toward the role of TNF-α in tumor-promoting inflammation, this updated study involves another factor in chemically induced carcinogenesis, namely immunological players ( 73 ). Our experience suggests that several inflammatory cytokines tested in serum match the evolution of skin tumors in mouse models ( 74 ).…”